Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Agency initiates safety label change and notifies physicians of possible link
Importantly, the combination of giredestrant and everolimus was well tolerated
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
Subscribe To Our Newsletter & Stay Updated
